Explore more publications!
Health Press Barbados
Got News to Share?

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 22, 2025

RxSight, Inc. Announces Chief Financial Officer Transition
December 22, 2025

RxSight, Inc. Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025

Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Apollomics Reports First Half 2025 Financial Results
December 22, 2025

Apollomics Reports First Half 2025 Financial Results

Indeterminate GlobeNewswire
TOMI Environmental Solutions Expands Footprint in Cell and Gene Therapy Sector with Multi-Stage SteraMist iHP Implementation at a New Pharmaceutical Manufacturing Site
December 22, 2025

TOMI Environmental Solutions Expands Footprint in Cell and Gene Therapy Sector with Multi-Stage SteraMist iHP Implementation at a New Pharmaceutical Manufacturing Site

Indeterminate GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 22, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
December 22, 2025

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

Indeterminate GlobeNewswire
Celularity Announces Closing of Financing Transactions
December 22, 2025

Celularity Announces Closing of Financing Transactions

Indeterminate GlobeNewswire
Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded.
December 22, 2025

Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded.

Indeterminate GlobeNewswire
Vivos Inc Summarizes Progress in its Animal Therapy Division
December 22, 2025

Vivos Inc Summarizes Progress in its Animal Therapy Division

Indeterminate GlobeNewswire
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
December 22, 2025

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

Indeterminate GlobeNewswire
NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
December 22, 2025

NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Indeterminate GlobeNewswire
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
December 22, 2025

AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040

Indeterminate GlobeNewswire
Le brevet pour le masitinib dans le traitement de la drépanocyose a été officiellement accordé aux Etats-Unis avec une protection jusqu'en 2040
December 22, 2025

Le brevet pour le masitinib dans le traitement de la drépanocyose a été officiellement accordé aux Etats-Unis avec une protection jusqu'en 2040

Indeterminate GlobeNewswire
The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS
December 22, 2025

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

Indeterminate GlobeNewswire
PracticeLink Supports the Next Generation of Clinicians with Fall 2025 First Practice Fund Scholarships
December 22, 2025

PracticeLink Supports the Next Generation of Clinicians with Fall 2025 First Practice Fund Scholarships

Indeterminate GlobeNewswire
Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain
December 22, 2025

Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain

Indeterminate GlobeNewswire
Wholeview Wellness Joins the Lumina Therapy Alliance, Expanding Access to In-Person Addiction-Focused Psychotherapy for Employees and Their Families
December 22, 2025

Wholeview Wellness Joins the Lumina Therapy Alliance, Expanding Access to In-Person Addiction-Focused Psychotherapy for Employees and Their Families

Indeterminate GlobeNewswire
First Health Canada-Approved At-Home COVID-19 and Influenza A/B Combination Test Now Available in Canada Ahead of Flu Season
December 22, 2025

First Health Canada-Approved At-Home COVID-19 and Influenza A/B Combination Test Now Available in Canada Ahead of Flu Season

Indeterminate GlobeNewswire
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
December 22, 2025

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

Indeterminate GlobeNewswire
MISTR & Kim Petras Celebrate Sexual Health in 2026
December 22, 2025

MISTR & Kim Petras Celebrate Sexual Health in 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions